EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparing GBA1 ‐Parkinson's disease and idiopathic Parkinson's disease: α‐Synuclein oligomers and synaptic density as biomarkers in the skin biopsy

Samanta Mazzetti iD, Elena Contaldi iD, Milo Jarno Basellini iD, Claudia Novello iD, Alessandra Maria Calogero iD, Letizia Straniero iD, Federica Garrì iD, Valentina Ferri, Daniela Calandrella iD, Francesca Del Sorbo iD, Rosanna Asselta iD, Emanuele Cereda iD und 3 weitere

Brain Pathology · 2024-11 · 34 (6)

DOI: 10.1111/bpa.13284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 01.09.2024. Verfasst von Samanta Mazzetti und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Università degli Studi di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Glucosylceramidase, Skin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione Grigioni per il Morbo di Parkinson, MUR, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale, Fondazione Regionale per la Ricerca Biomedica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main genetic risk factors for Parkinson's disease (PD) are presently represented by variants in GBA1 gene encoding for the β‐glucocerebrosidase (GCase). Searching for a peripheral biomarker that can be used for selecting and monitoring patients in clinical trials targeting GBA1 ‐associated PD ( GBA1 ‐PD) is a current challenge. We previously demonstrated that α‐synuclein oligomers expressed as proximity ligation assay (PLA) score in synaptic terminals of skin biopsy are a reliable biomarker for distinguishing idiopathic PD (iPD) from healthy controls (HC). This cross‐sectional study investigates an unexplored cohort of GBA1 ‐PD ( n = 27) compared to 28 HC, and 36 iPD cases to (i) analyze α‐synuclein oligomers and quantify them throughout PLA score, (ii) investigate GCase expression in brain and synaptic terminals targeting the sweat gland, (iii) unravel indicators that could differentiate patients with specific GBA1 mutations. PLA score discriminates GBA1 ‐PD from HC with sensitivity = 88.9% (95% CI 70.84–97.65), specificity = 88.5% (95% CI 69.85–97.55), and PPV = 88.9% (95% CI 73.24–95.90), AUC value = 0.927 (95% CI 0.859–0.996). No difference was found between GBA1 ‐PD patients and iPD, suggesting a common pathological pathway based on α‐synuclein oligomers. GCase score did not differ in GBA1 ‐PD, iPD, and HC in the synaptic terminals, whereas a positive correlation was found between PLA score and GCase score. Moreover, a significant increase in synaptic density was observed in GBA1 ‐PD compared to iPD and HC ( P < 0.0001). Employing ROC curve to discriminate GBA1 ‐PD from iPD, we found an AUC value for synaptic density = 0.855 (95% CI 0.749–0.961) with sensitivity = 85.2% (95% CI 66.27%–95.81%), specificity = 77.1% (95% CI 59.86%–89.58%), and PPV = 74.19% (60.53%–84.35%). The highest synaptic density values were observed in p.N409S patients. This work points out to the value of both PLA score and synaptic density in distinguishing GBA1 ‐PD from iPD and to their potential to stratify and monitor patients in the context of new pathway‐specific therapeutic options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson Diseasealpha-SynucleinGlucosylceramidaseSkinBiomarkersSynapsesHumansMaleFemaleAgedMiddle AgedBiopsyCross-Sectional StudiesMutationBrainAged, 80 and over

Stichwörter der Autor:innen

GBA1Parkinson's diseaseautonomic nervous systembiomarkerskin biopsyα‐synuclein

Substanzen

alpha-SynucleinGlucosylceramidaseBiomarkersGBA protein, human

Autor:innen und Institutionen

  • Department of Biosciences, Università degli Studi di Milano, Milan, Italy.
  • Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.
  • Parkinson Institute, ASST "G.Pini-CTO", Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Milan, Italy.
  • Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

ORCID-Profile: Samanta Mazzetti, Elena Contaldi, Milo Jarno Basellini, Claudia Novello, Alessandra Maria Calogero, Letizia Straniero, Federica Garrì, Daniela Calandrella, Francesca Del Sorbo, Rosanna Asselta, Emanuele Cereda, Graziella Cappelletti, Ioannis Ugo Isaias, Gianni Pezzoli

Förderung

  • Fondazione Grigioni per il Morbo di Parkinson
  • MUR, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale
  • Fondazione Regionale per la Ricerca Biomedica
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Mazzetti, S., Contaldi, E., Basellini, M. J., Novello, C., Calogero, A. M., Straniero, L., Garrì, F., Ferri, V., Calandrella, D., Del Sorbo, F., Asselta, R., Cereda, E., Cappelletti, G., Isaias, I. U., & Pezzoli, G. (2024). Comparing GBA1 ‐Parkinson's disease and idiopathic Parkinson's disease: α‐Synuclein oligomers and synaptic density as biomarkers in the skin biopsy. Brain Pathology, 34(6). https://doi.org/10.1111/bpa.13284

Vancouver

Mazzetti S, Contaldi E, Basellini MJ, Novello C, Calogero AM, Straniero L, et al. Comparing GBA1 ‐Parkinson's disease and idiopathic Parkinson's disease: α‐Synuclein oligomers and synaptic density as biomarkers in the skin biopsy. Brain Pathology. 2024;34(6). doi:10.1111/bpa.13284

BibTeX
@article{Mazzetti2024,
  author = {Mazzetti, Samanta and Contaldi, Elena and Basellini, Milo Jarno and Novello, Claudia and Calogero, Alessandra Maria and Straniero, Letizia and Garrì, Federica and Ferri, Valentina and Calandrella, Daniela and Del Sorbo, Francesca and Asselta, Rosanna and Cereda, Emanuele and Cappelletti, Graziella and Isaias, Ioannis Ugo and Pezzoli, Gianni},
  title = {Comparing GBA1 ‐Parkinson's disease and idiopathic Parkinson's disease: α‐Synuclein oligomers and synaptic density as biomarkers in the skin biopsy},
  journal = {Brain Pathology},
  year = {2024},
  volume = {34},
  number = {6},
  doi = {10.1111/bpa.13284}
}
Kostenlos starten →